Abstract:Purpose: New serum biomarkers are needed to improve the early detection of colorectal adenocarcinoma. We performed surface enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) to screen for differentially expressed proteins in serum and build a proteomic diagnostic pattern for the detection of colorectal adenocarcinoma to improve the prognosis of patients with this disease. Experimental Design: In an attempt to improve current approaches to the serologic diagnosis of colorectal cancer, we analyzed serum samples from subjects with or without colorectal cancer using SELDI-MS. Using a case-control study design, SELDI-MS profile of serum samples from 74 colorectal adenocarcinoma patients were compared with 48 age-and sex-matched healthy subjects using a ProteinChip reader, PBSII-C. Proteomic MS spectra were generated using IMAC3 chips, and protein peaks clustering and classification analyses were performed to build a proteomic pattern that could differentiate patients with colorectal adenocarcinoma from healthy subjects utilizing Biomarker Wizard and Biomarker Patterns software packages, respectively. The constructed pattern was then used to test an independent set of masked serum samples from 60 colorectal cancer patients and 39 healthy subjects.Results: Among the differentially expressed protein peaks identified by SELDI-MS profiling that had the ability to distinguish between patients and healthy subjects, we determined a minimum set of two protein peaks for system training and for developing a decision classification pattern. Masked analysis of an independent set of serum samples showed the diagnostic pattern could differentiate patients with different stages of colorectal cancer from healthy subjects with a sensitivity of 95.00 percent and specificity of 94.87 percent. Conclusion: SELDI-TOF-MS profiling of serum proteins combined with bioinformatics tools can be applied to accurately differentiate patients with colorectal cancer from healthy subjects. The high sensitivity and specificity achieved by the constructed clustering analysis algorithm show great potential for the early detection of colorectal cancer.

Proteomic Patterns in Serum of Lung Adenocarcinoma Patients and Its Correlation with Clinical TNM Stage

[Use of Laser Capture Microdissection and Surface-Enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Differential Proteins in Lung Adenocarcinoma and Lung Squamous Carcinoma].

The study of lung adenocarcinoma serum biomarkers selected by surface-enhanced laser desorption ionization spectrometry

Follow-up Analysis of Postoperative Serum Proteomic Patterns in Patients of Lung Adenocarcinoma

[Serum Proteomic Patterns May Assist the Diagnosis of Solitary Pulmonary Nodules].

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Detection and Significance of Serum Protein Markers of Small-Cell Lung Cancer

[Analysis of Serum Protein Fingerprints on Non-Small Cell Lung Cancer Lymphatic Metastasis].

Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.

A Serum Proteomic Pattern for the Detection of Colorectal Adenocarcinoma Using Surface Enhanced Laser Desorption and Ionization Mass Spectrometry

Serum Diagnosis Of Lung Adenocarcinoma Using Surface-Enhanced Laser Desorption And Ionization Mass Spectrometry

Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma

Study of Distinct Protein Profiles for Early Diagnosis of NSCLC Using LCM and SELDI-TOF-MS

SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis

[Surface Enhanced Laser Desorption/ionization Time-of-flight Mass Spectrometry Profiling of Serum in Detection of Laryngeal Squamous Cell Carcinoma and the Progression to Lymph Node Metastasis].

Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer

Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis

[Analysis of proteomic spectra in serum from patients with laryngeal carcinoma by SELDI-TOF-MS technology]

Study on Serum Biomarkers Screening for Gastric Cancer Using SELDI-TOF-MS Technology

Comparative Proteomic Analysis of Non-small-cell Lung Cancer and Normal Controls Using Serum Label-Free Quantitative Shotgun Technology

Preoperatively Molecular Staging with CM10 ProteinChip and SELDI-TOF-MS for Colorectal Cancer Patients